CLINICAL_TRIALS
trial_result
· 2020-01-09
Clinical Trial Update: The Study to YD312 Tablet in Patients With Diabetic Macular Edema [Phase 2]
Summary
Phase 2 trial update for YD312 tablet in diabetic macular edema.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: YD Global Life Science Co., Ltd. | Conditions: Diabetic Macular Edema(DME) | Phase 2 | Status: UNKNOWN